The scientists have noted a dramatic reduction in death of neurons in their Alzheimers model, for example, with the use of their peptide
Many patients notice improvement in pain, mobility, or recovery within 13 weeks
Well, lets go into the topic of today, which is that BPC 157
Introduction We focused on the stable gastric pentadecapeptide BPC 157 ( Thus, we suggest that one single application of the NO-synthase (NOS) blocker N(G)-nitro-L-arginine methyl ester (L-NAME) may induce retinal ischemia in rats, and that the stable pentadecapeptide BPC 157 may be the therapy, since it may interact with the NO-system and may counteract various adverse effects of L-NAME application (see In the previous eye research studies, BPC 157 counteracts atropine-mydriasis, but it also opposes an immediate and hour-lasting miotic effect of L-NAME in rats and guinea pigs, and participates in pupil control potentially via NO-mediated and cholinergic mechanisms ( This may be essential for the effective counteraction of the damaging effect of the retrobulbar L-NAME application
#regentalks #regenerativemedicine #innovation To view or add a comment, sign in Regenerative medicine is rapidly transforming healthcare, from novel macrophage therapies for liver disease to next-generation cell implants for Crohns patients
Our experts will recommend a comprehensive plan tailored to your overall health and wellness goals
